Search research articles
Contact Us
Filters
Showing results (61-70 of 76) with videos related to
Page
of 8
Sort By:
The Journal of Infectious Diseases
|
November 24, 1999
Waterborne outbreak of intestinal microsporidiosis in persons with and without human immunodeficiency virus infection
L Cotte, M Rabodonirina, F Chapuis, et al.
Journal of Viral Hepatitis
|
March 4, 2010
Proficiency of transient elastography compared to liver biopsy for the assessment of fibrosis in HIV/HBV-coinfected patients
P Miailhes, P Pradat, M Chevallier, et al.
Journal of Viral Hepatitis
|
August 6, 2013
Evolution of glomerular filtration rate in HIV-infected, HIV-HBV-coinfected and HBV-infected patients receiving tenofovir disoproxil fumarate
P Pradat, M-A Le Pogam, J-B Okon, et al.
L'Encephale
|
June 1, 2020
[Hepatitis C in a psychiatric setting: A forgotten reservoir?]
B Rolland, F Bailly, C Cutarella, et al.
Journal of Hepatology
|
July 1, 1994
Hepatitis C virus genotypes in France: comparison of clinical features of patients infected with HCV type I and type II
D Qu, J S Li, L Vitvitski, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin
|
November 7, 2014
Recent evidence of underestimated circulation of hepatitis C virus intergenotypic recombinant strain RF2k/1b in the Rhône-Alpes region, France, January to August 2014: implications for antiviral treatment
C Ramière, P Tremeaux, A Caporossi, et al.
Journal of Hepatology
|
August 29, 1998
Reinforced regimen of interferon alfa-2a reduces the incidence of cirrhosis in patients with chronic hepatitis C: a multicentre randomised trial. Multicentre GER-CYT-04 Group
F Degos, V Daurat, S Chevret, et al.
Gastroenterologie Clinique Et Biologique
|
September 9, 2008
Discordance between biochemical markers of liver activity and fibrosis (Actitest-Fibrotest) and liver biopsy in patients with chronic hepatitis C
T Fontanges, F Bailly, E Trepo, et al.
Journal of Hepatology
|
November 7, 1999
Prognostic value of the soluble interleukin-2 receptor in chronic hepatitis C treated with interferon-alfa. Multicenter GER-CYT 04 Group
S Naveau, A Balian, F Degos, et al.
Journal of Viral Hepatitis
|
June 20, 2007
Epidemiological characteristics and response to peginterferon plus ribavirin treatment of hepatitis C virus genotype 4 infection
D Roulot, V Bourcier, V Grando, et al.
Page
of 8
Search research articles
Search
Showing results (61-70 of 76) with videos related to
Sort By:
Page
of 8
The Journal of Infectious Diseases
|
November 24, 1999
Waterborne outbreak of intestinal microsporidiosis in persons with and without human immunodeficiency virus infection
L Cotte, M Rabodonirina, F Chapuis, et al.
Journal of Viral Hepatitis
|
March 4, 2010
Proficiency of transient elastography compared to liver biopsy for the assessment of fibrosis in HIV/HBV-coinfected patients
P Miailhes, P Pradat, M Chevallier, et al.
Journal of Viral Hepatitis
|
August 6, 2013
Evolution of glomerular filtration rate in HIV-infected, HIV-HBV-coinfected and HBV-infected patients receiving tenofovir disoproxil fumarate
P Pradat, M-A Le Pogam, J-B Okon, et al.
L'Encephale
|
June 1, 2020
[Hepatitis C in a psychiatric setting: A forgotten reservoir?]
B Rolland, F Bailly, C Cutarella, et al.
Journal of Hepatology
|
July 1, 1994
Hepatitis C virus genotypes in France: comparison of clinical features of patients infected with HCV type I and type II
D Qu, J S Li, L Vitvitski, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin
|
November 7, 2014
Recent evidence of underestimated circulation of hepatitis C virus intergenotypic recombinant strain RF2k/1b in the Rhône-Alpes region, France, January to August 2014: implications for antiviral treatment
C Ramière, P Tremeaux, A Caporossi, et al.
Journal of Hepatology
|
August 29, 1998
Reinforced regimen of interferon alfa-2a reduces the incidence of cirrhosis in patients with chronic hepatitis C: a multicentre randomised trial. Multicentre GER-CYT-04 Group
F Degos, V Daurat, S Chevret, et al.
Gastroenterologie Clinique Et Biologique
|
September 9, 2008
Discordance between biochemical markers of liver activity and fibrosis (Actitest-Fibrotest) and liver biopsy in patients with chronic hepatitis C
T Fontanges, F Bailly, E Trepo, et al.
Journal of Hepatology
|
November 7, 1999
Prognostic value of the soluble interleukin-2 receptor in chronic hepatitis C treated with interferon-alfa. Multicenter GER-CYT 04 Group
S Naveau, A Balian, F Degos, et al.
Journal of Viral Hepatitis
|
June 20, 2007
Epidemiological characteristics and response to peginterferon plus ribavirin treatment of hepatitis C virus genotype 4 infection
D Roulot, V Bourcier, V Grando, et al.
Page
of 8